Toggle navigation
Home
Search
Services
Blog
Contact
About
A Randomized Controlled Phase II Clinical Trial of Modulation of Inter-261995129
Johns Hopkins University, Baltimore, MD, United States
Search grants from Johns Hopkins University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Active, Enhanced Surveillance for Viral Hepatitis in San Francisco, California
Core - Histology
Preventive Medicine Residency Training
Training in Viral Molecular Biology and Immunology
Recently added grants:
QSM to Guide Iron Chelating Therapy in Transfusional Iron Overload
Semi-Parametric Subgroup Analysis for Longitudinal Data with Applications to Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Study
Regulation of Bile Acid Metabolism and Signaling in Metabolic Diseases
Novel Pathways for Kidney Stone Formation
Functional evaluation of a new GWAS locus that links visceral adiposity and type 2 diabetes
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA095129-002
Application #
6688608
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Related projects
NIH 2003
N01 CA
A Randomized Controlled Phase II Clinical Trial of Modulation of Inter-261995129
/ Johns Hopkins University
NIH 2002
N01 CA
A Randomized Controlled Phase II Clinical Trial of Modulation of Inter-261995129
/ Johns Hopkins University
Comments
Be the first to comment on this grant